Rationale and Objectives: Examine the accuracy of clinical non–small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Materials and Methods: Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) and 559 2010–2018 non-SEER single-institute surgically-treated cases, and analyze modifiable causes of disagreement. Results: The SEER clinical and pathological group-stages agree only 62.3% ± 0.9% over all stage categories. The lymph node N-stage agrees much better at 83.0% ± 1.0%, but the tumor length-location T-stage agrees only 57.7% ± 0.8% with approximately 29% of the cases having...
The aim of the study was to identify the most accurate CT window level setting for the measurement o...
IntroductionTumor size is a known prognostic factor for early stage non–small-cell lung cancer (NSCL...
IMPORTANCE Pathologic nodal stage is the most significant prognostic factor in resectable non-small ...
Rationale and Objectives: Examine the accuracy of clinical non–small cell lung cancer staging and tu...
Background: Tumor volume has been shown to be a prognostic factor for the response of some tumors to...
BackgroundTumor volume has been shown to be a prognostic factor for the response of some tumors to r...
The current TNM staging system for non-small cell lung cancer subdivides stage IA and IB according t...
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
Background. Hospitals lack intuitive methods to monitor their accuracy of clinical cancer staging, w...
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
ObjectiveThere is an increase in interest in limited resection for clinical stage IA non–small cell ...
Objectives: A prerequisite for utilizing the tumour, lymph-nodes, and metastases (TNM) for the stagi...
OBJECTIVE: This study was designed to characterize the reproducibility of measurement for tumor volu...
BackgroundIncreased tumor size is a known risk for poor outcomes in patients with stage I and II non...
Anatomical cancer extent is an important predictor of prognosis and determines treatment choices. In...
The aim of the study was to identify the most accurate CT window level setting for the measurement o...
IntroductionTumor size is a known prognostic factor for early stage non–small-cell lung cancer (NSCL...
IMPORTANCE Pathologic nodal stage is the most significant prognostic factor in resectable non-small ...
Rationale and Objectives: Examine the accuracy of clinical non–small cell lung cancer staging and tu...
Background: Tumor volume has been shown to be a prognostic factor for the response of some tumors to...
BackgroundTumor volume has been shown to be a prognostic factor for the response of some tumors to r...
The current TNM staging system for non-small cell lung cancer subdivides stage IA and IB according t...
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
Background. Hospitals lack intuitive methods to monitor their accuracy of clinical cancer staging, w...
BACKGROUND: Clinical staging of non-small cell lung cancer (NSCLC) helps determine the prognosis and...
ObjectiveThere is an increase in interest in limited resection for clinical stage IA non–small cell ...
Objectives: A prerequisite for utilizing the tumour, lymph-nodes, and metastases (TNM) for the stagi...
OBJECTIVE: This study was designed to characterize the reproducibility of measurement for tumor volu...
BackgroundIncreased tumor size is a known risk for poor outcomes in patients with stage I and II non...
Anatomical cancer extent is an important predictor of prognosis and determines treatment choices. In...
The aim of the study was to identify the most accurate CT window level setting for the measurement o...
IntroductionTumor size is a known prognostic factor for early stage non–small-cell lung cancer (NSCL...
IMPORTANCE Pathologic nodal stage is the most significant prognostic factor in resectable non-small ...